The plain-language read
Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation. Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes.
- Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes.
- Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation.
Relevant if you're working with urea, pha for aging and rosacea.
What this means for your routine
If you're targeting aging, this research supports adding urea to your AM/PM routine.
If you're targeting aging, this research supports adding pha to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
1. Cureus. 2026 Feb 17;18(2):e103757. doi: 10.7759/cureus.103757. eCollection 2026 Feb. Global Perspectives on Regional Sun Protection Factor (SPF) Requirements: Scientific and Regulatory Insights. Patel MN(1)(2), Patel N(1).
Full abstract→
1. Cureus. 2026 Feb 17;18(2):e103757. doi: 10.7759/cureus.103757. eCollection 2026 Feb. Global Perspectives on Regional Sun Protection Factor (SPF) Requirements: Scientific and Regulatory Insights. Patel MN(1)(2), Patel N(1). Author information: (1)Clinical Research Operations, NovoBliss Research Private Limited, Ahmedabad, IND. (2)Pharmacology, Swaminarayan University, Ahmedabad, IND. Ultraviolet (UV) radiation is a well-established environmental factor contributing to acute and chronic skin damage, including erythema, photoaging, pigmentary disorders, and skin cancer. Sunscreens represent a cornerstone of photoprotection strategies, with sun protection factor (SPF) serving as the primary measure of protection against UVB-induced erythema. However, UV exposure varies considerably across geographic regions due to differences in latitude, climate, altitude, and lifestyle, necessitating region-specific SPF recommendations. In parallel, sunscreen regulation and SPF claim substantiation differ across global jurisdictions, influencing product development, labeling, and consumer communication. This scientific communication reviews the biological basis of UV-induced skin damage, the rationale for region-wise SPF selection, and the regulatory frameworks governing sunscreen efficacy and claims across major global authorities, including India (Bureau of Indian Standards (BIS)), the European Union (EU; European Cosmetic, Toiletry and Perfumery Association (COLIPA)), the United States (Food and Drug Administration (FDA)), Australia (Therapeutic Goods Administration (TGA)), Canada (Health Canada), and Japan (Ministry of Health, Labour and Welfare (MHLW)/Japan Cosmetic Industry Association (JCIA)). While regulatory approaches differ in classification, UVA assessment methodologies, and labeling systems, there is a shared scientific consensus on the importance of validated SPF testing, broad-spectrum protection, and responsible communication. Harmonization through international testing standards has improved comparability of sunscreen efficacy, although regulatory diversity continues to pose challenges for global implementation. Integrating scientific evidence with existing region-specific regulatory requirements is essential for effective photoprotection, informed sunscreen use, and improved public health outcomes. Copyright © 2026, Patel et al. DOI: 10.7759/cureus.103757 PMCID: PMC13000865 PMID: 41869094 Conflict of interest statement: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Original source →Does Astragalus mongholicus Bunge help promote the healing of wounds? A systematic review and meta-analysis of preclinical animal studies.
Wounds continue to represent a significant public health challenge globally. In recent years, Astragalus mongholicus Bunge, a traditional Chinese botanical drug utilized for wound treatment, has garnered increasing research attention. However, the therapeutic efficacy and safety of this natural botanical drug on wound healing remain poorly understood.
Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.
Recent preclinical studies have shown that nicotinamide adenine dinucleotide (NAD+) plays a critical role in molecular mechanisms of axon degeneration, and reductions in NAD+ levels are associated with axonal degeneration. Nicotinamide riboside (NR) is a safe and widely available pyridine-nucleoside form of vitamin B3 and is an NAD+ precursor. To investigate if oral supplementation of synthetic NR can act as a therapeutic agent to prevent degeneration of small somatic sensory axons innervating the skin or promote regeneration of these same fibers in humans, we utilized a validated experimental model of cutaneous nerve degeneration and regeneration and conducted a placebo-controlled, double-blinded Phase 2 study.
Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.
Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear. To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation. In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days.